Loading...
Givaudan SA
GVDBF•PNK
Basic Materials
Chemicals - Specialty
$5008.62
$-266.38(-5.05%)
Givaudan SA (GVDBF) Financial Performance & Statements
Review Givaudan SA’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
7.19%
↑ 7.19%
Operating Income Growth
24.91%
↑ 24.91%
Net Income Growth
22.06%
↑ 22.06%
Operating Cash Flow Growth
18.35%
↑ 18.35%
Operating Margin
17.76%
↑ 17.76%
Gross Margin
41.83%
↑ 41.83%
Net Profit Margin
14.50%
↑ 14.50%
ROE
23.21%
↑ 23.21%
ROIC
13.64%
↑ 13.64%
Givaudan SA (GVDBF) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for Givaudan SA stock.
| Metric | Q2 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|
| Revenue | $3.74B | $3.38B | $1.69B | $3.54B |
| Cost of Revenue | $2.09B | $2.05B | $991.00M | $2.15B |
| Gross Profit | $1.65B | $1.33B | $699.00M | $1.39B |
| Gross Profit Ratio | $0.44 | $0.39 | $0.41 | $0.39 |
| R&D Expenses | $280.00M | $242.00M | $128.50M | $244.00M |
| SG&A Expenses | $589.00M | $515.00M | $278.50M | $513.00M |
| Operating Expenses | $917.00M | $796.00M | $437.00M | $807.00M |
| Total Costs & Expenses | $3.008B | $2.85B | $1.43B | $2.95B |
| Interest Income | $17.00M | $5.00M | $25.50M | $3.00M |
| Interest Expense | $56.00M | $56.00M | $0.00 | $58.00M |
| Depreciation & Amortization | $173.00M | $179.00M | $36.50M | $177.00M |
| EBITDA | $902.00M | $714.00M | $302.50M | $379.50M |
| EBITDA Ratio | $0.24 | $0.21 | $0.18 | $0.21 |
| Operating Income | $729.00M | $535.00M | $266.00M | $581.00M |
| Operating Income Ratio | $0.20 | $0.16 | $0.16 | $0.16 |
| Other Income/Expenses (Net) | -$29.00M | -$298.50M | -$29.50M | -$323.00M |
| Income Before Tax | $700.00M | $471.00M | $236.50M | $513.00M |
| Income Before Tax Ratio | $0.19 | $0.14 | $0.14 | $0.15 |
| Income Tax Expense | $112.00M | $29.00M | $14.50M | $67.00M |
| Net Income | $588.00M | $444.00M | $222.00M | $449.00M |
| Net Income Ratio | $0.16 | $0.13 | $0.13 | $0.13 |
| EPS | $63.76 | $48.12 | $23.97 | $48.69 |
| Diluted EPS | $63.50 | $47.95 | $23.97 | $48.53 |
| Weighted Avg Shares Outstanding | $9.22M | $9.23M | $9.26M | $9.22M |
| Weighted Avg Shares Outstanding (Diluted) | $9.26M | $9.26M | $9.26M | $9.25M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan